Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| A Kinase Anchor Proteins | 8 | 2024 | 11 | 3.760 |
Why?
|
| Cell Cycle Proteins | 6 | 2024 | 19 | 2.490 |
Why?
|
| Myocardium | 6 | 2020 | 34 | 2.330 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 7 | 2024 | 12 | 2.090 |
Why?
|
| Signal Transduction | 7 | 2019 | 216 | 1.450 |
Why?
|
| Myocytes, Cardiac | 7 | 2024 | 40 | 1.030 |
Why?
|
| Animals | 17 | 2024 | 1711 | 0.940 |
Why?
|
| Cyclic AMP | 3 | 2020 | 11 | 0.890 |
Why?
|
| Stem Cells | 3 | 2020 | 33 | 0.890 |
Why?
|
| Calcium | 4 | 2024 | 31 | 0.850 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2024 | 1 | 0.850 |
Why?
|
| Receptors, Adrenergic | 1 | 2024 | 3 | 0.840 |
Why?
|
| Heart Diseases | 1 | 2024 | 11 | 0.840 |
Why?
|
| Protein Transport | 2 | 2022 | 30 | 0.830 |
Why?
|
| Heart Failure | 2 | 2024 | 30 | 0.830 |
Why?
|
| Cell Differentiation | 4 | 2019 | 71 | 0.800 |
Why?
|
| Diet, High-Fat | 2 | 2019 | 34 | 0.750 |
Why?
|
| Atherosclerosis | 2 | 2019 | 16 | 0.740 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2022 | 14 | 0.730 |
Why?
|
| Mice | 12 | 2024 | 685 | 0.730 |
Why?
|
| Drug Discovery | 1 | 2022 | 15 | 0.720 |
Why?
|
| Membrane Proteins | 1 | 2022 | 47 | 0.690 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 225 | 0.670 |
Why?
|
| Ventricular Function | 1 | 2020 | 1 | 0.650 |
Why?
|
| Second Messenger Systems | 1 | 2020 | 4 | 0.650 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 36 | 0.640 |
Why?
|
| Sinoatrial Node | 1 | 2020 | 2 | 0.640 |
Why?
|
| Pacemaker, Artificial | 1 | 2020 | 4 | 0.640 |
Why?
|
| Biological Clocks | 1 | 2019 | 9 | 0.620 |
Why?
|
| Humans | 14 | 2024 | 4936 | 0.620 |
Why?
|
| Aortic Diseases | 1 | 2019 | 4 | 0.610 |
Why?
|
| Aorta | 1 | 2019 | 8 | 0.610 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2019 | 7 | 0.610 |
Why?
|
| Hyperlipidemias | 1 | 2019 | 9 | 0.600 |
Why?
|
| Lipids | 1 | 2019 | 20 | 0.600 |
Why?
|
| HEK293 Cells | 4 | 2022 | 30 | 0.570 |
Why?
|
| Pericardium | 1 | 2018 | 3 | 0.570 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 7 | 0.570 |
Why?
|
| Calcinosis | 1 | 2018 | 5 | 0.570 |
Why?
|
| Cardiomegaly | 2 | 2016 | 4 | 0.570 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 3 | 0.540 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 43 | 0.530 |
Why?
|
| Intracellular Space | 1 | 2017 | 3 | 0.520 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 9 | 0.520 |
Why?
|
| Mutation | 1 | 2017 | 132 | 0.480 |
Why?
|
| Heart | 3 | 2024 | 48 | 0.470 |
Why?
|
| Heart Function Tests | 2 | 2016 | 4 | 0.440 |
Why?
|
| Male | 8 | 2024 | 2491 | 0.420 |
Why?
|
| Phosphorylation | 5 | 2019 | 48 | 0.420 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2013 | 8 | 0.410 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 73 | 0.410 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2019 | 23 | 0.340 |
Why?
|
| Muscular Atrophy | 2 | 2021 | 21 | 0.330 |
Why?
|
| Transcription Factors | 3 | 2024 | 66 | 0.320 |
Why?
|
| Isoproterenol | 2 | 2024 | 3 | 0.310 |
Why?
|
| Mice, Knockout | 4 | 2022 | 140 | 0.250 |
Why?
|
| Electrocardiography | 2 | 2018 | 13 | 0.240 |
Why?
|
| Binding Sites | 2 | 2018 | 66 | 0.240 |
Why?
|
| Protein Binding | 2 | 2018 | 115 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 3 | 2022 | 184 | 0.220 |
Why?
|
| Regeneration | 1 | 2024 | 15 | 0.220 |
Why?
|
| Carrier Proteins | 2 | 2015 | 23 | 0.210 |
Why?
|
| Transcriptome | 3 | 2019 | 43 | 0.210 |
Why?
|
| Up-Regulation | 1 | 2024 | 28 | 0.210 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 18 | 0.190 |
Why?
|
| Luciferases | 1 | 2022 | 2 | 0.180 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 2 | 0.180 |
Why?
|
| Adipocytes | 1 | 2022 | 4 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 2 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2022 | 5 | 0.180 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 78 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 1 | 2022 | 24 | 0.180 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 14 | 0.180 |
Why?
|
| Nanotechnology | 1 | 2022 | 29 | 0.180 |
Why?
|
| Mice, SCID | 2 | 2018 | 9 | 0.170 |
Why?
|
| Phenotype | 2 | 2018 | 67 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2021 | 53 | 0.170 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 11 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2019 | 4 | 0.160 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 8 | 0.160 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 5 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 9 | 0.160 |
Why?
|
| Connexins | 1 | 2019 | 6 | 0.150 |
Why?
|
| Myoblasts | 1 | 2019 | 10 | 0.150 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2019 | 2 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 2 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 7 | 0.150 |
Why?
|
| Neointima | 1 | 2019 | 8 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2019 | 15 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 11 | 0.150 |
Why?
|
| Liver | 1 | 2019 | 49 | 0.150 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 4 | 0.150 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2018 | 13 | 0.140 |
Why?
|
| Mice, Inbred Strains | 1 | 2018 | 6 | 0.140 |
Why?
|
| Echocardiography | 1 | 2018 | 9 | 0.140 |
Why?
|
| Autophagy | 1 | 2018 | 30 | 0.140 |
Why?
|
| Female | 2 | 2024 | 2523 | 0.130 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 2 | 0.130 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2017 | 4 | 0.130 |
Why?
|
| Cytosol | 1 | 2017 | 7 | 0.130 |
Why?
|
| Cell Proliferation | 4 | 2019 | 115 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 6 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 10 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 12 | 0.120 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 154 | 0.120 |
Why?
|
| Histone Chaperones | 1 | 2016 | 3 | 0.120 |
Why?
|
| Acetylcysteine | 1 | 2016 | 1 | 0.120 |
Why?
|
| Sarcolemma | 1 | 2016 | 6 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2016 | 11 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 9 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 14 | 0.120 |
Why?
|
| Cytokinesis | 1 | 2015 | 1 | 0.120 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2013 | 1 | 0.100 |
Why?
|
| Sarcomeres | 1 | 2013 | 1 | 0.100 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 6 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 6 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2013 | 15 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2013 | 16 | 0.100 |
Why?
|
| CHO Cells | 1 | 2013 | 17 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 14 | 0.100 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 16 | 0.100 |
Why?
|
| Cricetinae | 1 | 2013 | 21 | 0.100 |
Why?
|
| Cricetulus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2019 | 127 | 0.070 |
Why?
|
| Serum Response Factor | 1 | 2024 | 3 | 0.060 |
Why?
|
| Rats | 1 | 2024 | 241 | 0.050 |
Why?
|
| Acylation | 1 | 2022 | 1 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2022 | 2 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2021 | 4 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 8 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2019 | 3 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2019 | 7 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 13 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 9 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 9 | 0.040 |
Why?
|
| Base Sequence | 1 | 2019 | 63 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 18 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 68 | 0.040 |
Why?
|
| Cell Movement | 1 | 2019 | 61 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2018 | 6 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2018 | 16 | 0.040 |
Why?
|
| Coronary Vessels | 1 | 2018 | 27 | 0.040 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 3 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2016 | 3 | 0.030 |
Why?
|
| Wnt3A Protein | 1 | 2016 | 3 | 0.030 |
Why?
|
| Mesoderm | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 15 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 19 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 9 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 3 | 0.030 |
Why?
|
| DNA Repair | 1 | 2016 | 6 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 7 | 0.030 |
Why?
|
| Renal Agents | 1 | 2016 | 2 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 14 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 9 | 0.030 |
Why?
|
| Fetus | 1 | 2016 | 11 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 20 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2016 | 11 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 26 | 0.030 |
Why?
|
| Hospitalization | 1 | 2016 | 38 | 0.030 |
Why?
|
| Prevalence | 1 | 2016 | 66 | 0.030 |
Why?
|
| Apoptosis | 1 | 2016 | 46 | 0.030 |
Why?
|
| Dependovirus | 1 | 2015 | 1 | 0.030 |
Why?
|
| Aurora Kinases | 1 | 2015 | 1 | 0.030 |
Why?
|
| Histones | 1 | 2015 | 12 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 31 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 34 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2015 | 21 | 0.030 |
Why?
|
| Risk Factors | 1 | 2016 | 159 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2016 | 177 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2016 | 58 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 35 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 47 | 0.030 |
Why?
|
| Biomarkers | 1 | 2015 | 81 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 318 | 0.030 |
Why?
|
| Models, Biological | 1 | 2015 | 124 | 0.030 |
Why?
|
| Aged | 1 | 2016 | 703 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 967 | 0.020 |
Why?
|